Sorbonne University spin-out Carthera SA has closed its Series B financing round with an additional investment of €4.5m at €42m to launch clinical trials.
https://european-biotechnology.com/wp-content/uploads/2024/04/Carthera-Sonocloud-9.png487650Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2023-12-11 15:22:052024-07-09 13:03:14Cathera SA closes Series B round at €42m